FilingsAtlas Logo - Company Search & Market Tools
FilingsAtlas

Vivani Medical, Inc. (VANI) Financial Statements

Industry: Electromedical & Electrotherapeutic Apparatus

In fiscal 2025, Vivani Medical reported revenue of $0. Net income was -$26.6M, or -$0.43 per diluted share. Operating activities generated -$24.3M of cash, leaving -$25.5M of free cash flow. At fiscal year end, Vivani Medical held $39.4M in total assets against $23.7M in total liabilities, including $16.2M of cash and equivalents.

Open the full interactive Vivani Medical financials → Quarterly statements, key ratios, valuation history and price charts.

Vivani Medical Key Stats

Share Price$1.18
Market Cap$102.8M
52-Week Range$0.94 – $1.87
Shares Outstanding87.1 million (basic, 2026 Q2)

Vivani Medical Income Statement

Vivani Medical, Inc. annual income statement
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$1.0M$260,000$0$0$0$0
Cost of Goods Sold$500,000$130,000————
Gross Profit$500,000$130,000————
Operating Income-$14.9M-$8.9M-$21.2M-$27.0M-$24.7M-$27.6M
Pre-Tax Income-$14.9M-$8.9M-$13.9M-$25.7M-$23.5M-$26.6M
Net Income-$14.9M-$8.9M-$13.9M-$25.7M-$23.5M-$26.6M
Diluted EPS-$2.16-$0.81——-$0.43-$0.43

Vivani Medical Quarterly Results

Vivani Medical, Inc. last 4 quarters
2025 Q32025 Q42026 Q12026 Q2
Revenue$0$0$0$0
Net Income-$6.5M-$6.6M-$6.8M-$6.4M
Diluted EPS-$0.11-$0.11-$0.08-$0.07

Vivani Medical Balance Sheet

Vivani Medical, Inc. annual balance sheet (fiscal year end)
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash & Equivalents$3.2M$69.6M—$20.7M$18.4M$16.2M
Current Assets$4.3M$70.5M$47.5M$23.1M$20.4M$17.9M
Total Assets$4.5M$70.9M$51.1M$45.8M$41.6M$39.4M
Current Liabilities$5.1M$2.5M$6.8M$5.7M$6.0M$6.6M
Total Liabilities$5.1M$2.5M$6.8M$25.0M$24.0M$23.7M
Shareholders' Equity-$672,000$68.4M$44.3M$20.8M$17.6M$15.7M

Vivani Medical Cash Flow Statement

Vivani Medical, Inc. annual cash flow statement
FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash From Operations-$16.8M-$9.2M-$18.8M-$23.7M-$20.8M-$24.3M
Cash From Investing$68,000-$14,000-$338,000-$887,000-$556,000-$1.2M
Cash From Financing$8.6M$75.6M$63.4M$133,000$19.1M$23.3M
Free Cash Flow-$17.2M-$9.2M-$19.1M-$24.6M-$21.3M-$25.5M

Figures from Vivani Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Vivani Medical financials page for every line item.

Vivani Medical Company Profile

TickerVANI
ExchangeNasdaq
IndustryElectromedical & Electrotherapeutic Apparatus
HeadquartersAlameda, California
Incorporated inDelaware
Fiscal Year EndDecember 31
SEC Filer CategoryNon-accelerated filer, smaller reporting company
SEC CIK0001266806

Frequently Asked Questions

What was Vivani Medical's revenue in fiscal 2025?

Vivani Medical (VANI) reported revenue of $0 for fiscal 2025.

What is Vivani Medical's annual revenue history?

Vivani Medical's annual revenue by fiscal year: 2020: $1.0M; 2021: $260,000; 2022: $0; 2023: $0; 2024: $0; 2025: $0.

What was Vivani Medical's net income in fiscal 2025?

Vivani Medical reported net income of -$26.6M for fiscal 2025.

What was Vivani Medical's earnings per share (EPS) in fiscal 2025?

Vivani Medical's diluted EPS was -$0.43 for fiscal 2025 (adjusted for any later stock splits).

How much free cash flow did Vivani Medical generate in fiscal 2025?

Vivani Medical generated -$25.5M of free cash flow in fiscal 2025.

What was Vivani Medical's revenue last quarter?

In its most recent reported quarter (2026 Q2), Vivani Medical reported revenue of $0.

How many shares of Vivani Medical are outstanding?

Vivani Medical reported a weighted average of 87.1 million basic shares outstanding in 2026 Q2.

What is Vivani Medical's market cap?

Based on its latest closing price, Vivani Medical (VANI) has a market capitalization of about $102.8M.

When does Vivani Medical's fiscal year end?

Vivani Medical's fiscal year end, as registered with the SEC, is December 31.

Where is Vivani Medical headquartered?

Vivani Medical lists its business address in Alameda, California in its SEC filings.